about
Generation and characterization of transgene-free human induced pluripotent stem cells and conversion to putative clinical-grade statusGermline stem cells: toward the regeneration of spermatogenesisEnhanced generation of induced pluripotent stem cells from a subpopulation of human fibroblastsRapid and efficient conversion of integration-free human induced pluripotent stem cells to GMP-grade culture conditionsParthenogenic blastocysts derived from cumulus-free in vitro matured human oocytes.From intestine to muscle: nuclear reprogramming through defective cloned embryos.Producing primate embryonic stem cells by somatic cell nuclear transfer.Identifying candidate oocyte reprogramming factors using cross-species global transcriptional analysisCurrent progress with primate embryonic stem cellsHeterozygous embryonic stem cell lines derived from nonhuman primate parthenotes.Restoring Ureagenesis in Hepatocytes by CRISPR/Cas9-mediated Genomic Addition to Arginase-deficient Induced Pluripotent Stem Cells.Putative immunogenicity expression profiling using human pluripotent stem cells and derivatives.Derivation and characterization of a transgene-free human induced pluripotent stem cell line and conversion into defined clinical-grade conditions.Isolation and characterization of novel rhesus monkey embryonic stem cell lines.Investigating the functionality of an OCT4-short response element in human induced pluripotent stem cells.Developing neural stem cell-based treatments for neurodegenerative diseases.Commentary on human cloning.Nuclei of adult mammalian somatic cells are directly reprogrammed to oct-4 stem cell gene expression by amphibian oocytes.Transcriptional profiling of rhesus monkey embryonic stem cellsThe first half-century of nuclear transplantation
P50
Q21999273-F7ECCE52-4D2B-4D7F-9C1F-B7F796257936Q27011412-02BE9B1F-CFA8-4FB3-8B0B-5C1D1916839CQ27341904-7CCC23B0-F667-47CB-A0C7-CB3E3D58F1D1Q27342678-51819B07-5220-4D0E-9CD4-32D97707908EQ33601498-3ACE7E35-9EDA-437C-BDCE-475A67125010Q34027857-97BD327E-1713-4AB7-AB8E-6C1FFD8DD111Q34713822-4DC4460A-CF9B-4B38-9A75-F405B9F2D051Q36739919-4D05662E-6D69-4199-8DD2-B5C9029C2092Q37066438-D0796CFE-125C-4C80-A767-1F024DC91393Q37421338-A5987A23-82E8-4DF8-9F67-DF3E59BFAA60Q37501605-5819A55F-E1FB-45FB-A90E-7E6E305567DBQ38921558-7CA963E5-94A1-4085-B2EA-14D28BE456ADQ38930645-B2227710-4E20-45B6-B454-1C40DA2EBD4CQ40272419-8DCFF8E0-EEB6-48B9-8352-DC30DA2306D2Q40631630-33F39298-1C32-4B92-80CA-1665D18F6B17Q41547468-EB57DD28-E1AA-477E-8788-40EF27B16611Q48559542-611A41AE-E49A-45CF-9712-D0BAAA8EC6E8Q48824967-8805B373-D327-4B58-BB7D-101DBD129E95Q80192605-B162DCAF-2CB8-4998-8F4D-132496DED58BQ81142837-621E59B2-F2F5-4ED6-9055-7481C72C960E
P50
description
Forscher
@de
investigador
@es
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
研究者
@zh
name
James A Byrne
@ast
James A Byrne
@en
James A Byrne
@es
James A Byrne
@nl
type
label
James A Byrne
@ast
James A Byrne
@en
James A Byrne
@es
James A Byrne
@nl
altLabel
J A Byrne
@en
prefLabel
James A Byrne
@ast
James A Byrne
@en
James A Byrne
@es
James A Byrne
@nl
P106
P31
P496
0000-0002-2232-292X